Ph.D., Chief Scientific Officer, Metabolon
Biography
Dr. Sarangarajan is a recognized R&D leader. As the CSO and SVP Clinical and Translational Sciences at BERG, he led multi-functional teams integrating biology, technology, and artificial intelligence analytics in the development of a multi-omic, biology-based platform for the discovery of disease-specific targets, therapeutic discovery, and diagnostics development. Ranga obtained his Ph.D., in Pharmaceutical Sciences from the University of Cincinnati and a B.S., in Pharmacy from Maharaja Sayajirao University.
Session Abstract – PMWC 2022 Silicon Valley
Track 5 - June 30 9.15 A.M.-10.15 A.M.
Panel
Session Abstract – PMWC 2022 Silicon Valley
Track 5 - June 30 9.15 A.M.-10.15 A.M.
Track Chair:
Rita Colwell, Johns Hopkins Bloomberg School of Public Health
Manoj Dadlani, CosmosID
Understanding mechanism of action and translating microbiome science into commercially viable therapeutics remains the biggest challenge in this emerging field. With that said, pharma and biotech across many different therapeutic indications and modalities are united in this global effort to bring novel microbiome-based therapies and diagnostics into the clinical domain. This session will include some of the most impactful and promising areas of the Microbiome field and panel discussions on the challenges for faster adoption.
-
Sessions:
- Intro and Overview to Microbiome
- Manoj Dadlani, CosmosID - Pharma Drug Development (PANEL)
Session Chair: Karim Dabbagh, Second Genome
- Jennifer Wortman, Seres Therapeutics
- Paul Garofolo, Locus Biosciences
- Rangaprasad Sarangarajan, Metabolon - AI in Microbiome
- Agnieszka Piotrowska, Ardigen
- Direct-To-Consumer Testing/Technologies (PANEL)
Session Chair: Nathan D. Price, Thorne HealthTech
- Kiran Krishnan, Microbiome Labs
- Nicole Scott, Cybele Microbiome
- Noosheen Hashemi, January AI - The Role of the Human Gut Microbiome on Various Diseases
- Colleen Cutcliffe, Pendulum Therapeutics
- Tor Savidge, Baylor College of Medicine
- Nikole Kimes, Siolta Therapeutics
- Susan Lynch, UCSF - The Gut/Brain Microbiome
- Mary Conrad, Axial Biotherapeutics
- Christopher Reyes, Bloom Science
- Evolutionary Biology of the Skin Microbiome
- Larry Weiss, Symbiome - Showcase
- Heloise Breton, DNA Genotek
- Nathan Price, Thorne HealthTech
- Mo Langhi, CosmosID
- Rangaprasad Sarangarajan, Metabolon
